United States securities and exchange commission logo

                          November 13, 2020

       Michael Bailey
       President & Chief Executive Officer
       AVEO Pharmaceuticals, Inc.
       30 Winter Street
       Boston, Massachusetts 02108

                                                        Re: AVEO
Pharmaceuticals, Inc.
Statement on Form S-3
                                                            Filed November 9,
                                                            File No. 333-249982

       Dear Mr. Bailey:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Tim
Buchmiller at (202) 551-3635 with any questions.


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Cynthia T. Mazareas,